Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Dementia in Parkinson's Disease
NCT00030979Phase 4Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in Parkinson's disease dementia (PDD), sponsored by National Institute of Neurological Disorders and Stroke. Started Feb 2002; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT00030979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030979.